Mario Poljak Selected Research

Mario Poljak Research Topics

Disease

32	Infections 06/2022 - 09/2002
19	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 08/2009
16	Neoplasms (Cancer) 01/2021 - 12/2011
15	Papillomavirus Infections 01/2021 - 01/2005
11	Carcinoma (Carcinomatosis) 12/2020 - 09/2003
8	Papilloma (Papillomatosis) 10/2021 - 08/2012
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2021 - 09/2003
7	Warts (Wart) 12/2016 - 01/2011
5	COVID-19 02/2022 - 01/2021
5	Squamous Cell Carcinoma of Head and Neck 11/2017 - 09/2003
5	Hepatitis C 05/2014 - 01/2003
5	Chronic Hepatitis C 01/2014 - 09/2002
4	Chronic Hepatitis B 06/2022 - 09/2002
3	Hepatitis 06/2022 - 10/2013
3	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2018
3	Uterine Cervical Dysplasia 01/2022 - 11/2012
3	Recurrent respiratory papillomatosis 12/2014 - 09/2011
3	Viremia 02/2014 - 09/2002
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2014 - 11/2004
3	Hepatitis B 10/2013 - 01/2004
3	Carcinogenesis 05/2009 - 09/2003
2	Condylomata Acuminata (Genital Wart) 01/2018 - 12/2013
2	Head and Neck Neoplasms (Head and Neck Cancer) 06/2016 - 12/2012
2	Anus Neoplasms (Anal Cancer) 01/2015 - 09/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 11/2004
2	HIV Infections (HIV Infection) 01/2014 - 01/2004
2	Disease Progression 06/2010 - 09/2002
2	Hyperplasia 03/2005 - 09/2003
1	Adenocarcinoma in Situ 10/2021
1	Critical Illness (Critically Ill) 01/2018
1	Adenocarcinoma 11/2017
1	Progressive Multifocal Leukoencephalopathy 03/2016
1	Pneumonia (Pneumonitis) 01/2015
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 01/2015
1	Septic Shock (Toxic Shock Syndrome) 09/2014
1	Sepsis (Septicemia) 09/2014
1	Peripheral Arterial Disease 05/2014
1	Inflammation (Inflammations) 01/2014
1	Atherosclerosis 01/2014

Drug/Important Bio-Agent (IBA)

34	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2002
22	VaccinesIBA 02/2022 - 08/2009
12	Papillomavirus Vaccines (HPV Vaccines)IBA 08/2021 - 11/2013
9	RNA (Ribonucleic Acid)IBA 03/2021 - 11/2004
7	Messenger RNA (mRNA)IBA 01/2022 - 09/2003
7	AntibodiesIBA 01/2021 - 04/2013
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2003
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2022 - 10/2013
4	ParaffinIBA 06/2016 - 07/2011
4	Formaldehyde (Formol)FDA Link 06/2016 - 07/2011
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2019
3	AntigensIBA 01/2021 - 02/2005
3	Ribavirin (Virazole)FDA LinkGeneric 05/2014 - 02/2005
3	Interferon-alpha (Interferon Alfa)IBA 10/2013 - 09/2002
3	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2005 - 09/2003
2	Hepatitis B e AntigensIBA 09/2018 - 10/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 11/2014
2	Viral ProteinsIBA 11/2017 - 03/2016
2	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2016 - 01/2015
2	Nucleic AcidsIBA 03/2016 - 02/2005
2	Antiviral Agents (Antivirals)IBA 01/2015 - 09/2002
2	beta-Globins (beta Globin)IBA 01/2015 - 08/2009
2	Reverse Transcriptase InhibitorsIBA 07/2014 - 04/2011
2	InterferonsIBA 05/2014 - 01/2014
2	Combined VaccinesIBA 08/2012 - 09/2011
2	Proteins (Proteins, Gene)FDA Link 04/2011 - 03/2005
2	EnzymesIBA 12/2006 - 09/2003
2	cyclopropapyrroloindoleIBA 04/2005 - 01/2005
1	Surface Antigens (Surface Antigen)IBA 06/2022
1	COVID-19 VaccinesIBA 02/2022
1	2019-nCoV Vaccine mRNA-1273IBA 02/2022
1	SilverIBA 10/2021
1	MucinsIBA 10/2021
1	Hepatitis C AntibodiesIBA 09/2020
1	Virulence Factors (Pathogenicity Factors)IBA 09/2019
1	Terminator Codon (Termination Codon)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	OzoneIBA 06/2017
1	nasIBA 01/2016
1	entecavir FDA Link 01/2016
1	Tenofovir (Viread)FDA Link 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 11/2014
1	Docetaxel (Taxotere)FDA Link 11/2014
1	Cetuximab (Erbitux)FDA Link 11/2014
1	NitritesIBA 10/2014
1	NucleosidesIBA 07/2014
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 05/2014
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2014
1	C-Reactive ProteinIBA 01/2014
1	Fluvastatin FDA Link 01/2014
1	Plasminogen Activator Inhibitor 1IBA 01/2014

Therapy/Procedure

13	Therapeutics 09/2016 - 09/2002
3	Aftercare (After-Treatment) 08/2021 - 04/2011
3	Renal Dialysis (Hemodialysis) 12/2019 - 01/2003
2	Radiotherapy 01/2018 - 12/2011
2	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 11/2004
1	Artificial Respiration (Mechanical Ventilation) 02/2022
1	Personal Protective Equipment 03/2021
1	Critical Care (Surgical Intensive Care) 01/2018
1	Induction Chemotherapy 11/2014
1	Liver Transplantation 05/2014